NBOCA Outlier Reporting 2023 onwards
Risk-adjusted 2-year mortality will be outlier reported in 2023. From 2024, outlier reporting will resume for all of the NBOCA trust/MDT outcomes.
Risk-adjusted 2-year mortality will be outlier reported in 2023. From 2024, outlier reporting will resume for all of the NBOCA trust/MDT outcomes.
NBOCA has moved into the National Cancer Audit Collaborating Centre and the Royal College of Surgeons of England. Future reporting will use existing national datasets.
The aim of this methodological report was to assess the validity of information on post-operative destination for colorectal cancer patients undergoing emergency surgery across three routinely collected datasets.
Unique opportunity to work at the new National Cancer Audit Collaborating Centre (NATCAN) at the Royal College of Surgeons of England
Final deadline for data being uploaded to CAP for the 2023 NBOCA annual report.
This report includes patients diagnosed with bowel cancer in England and Wales between 01 April 2020 and 31 March 2021, and patients diagnosed between 01 April 2019 and 31 March 2020 who underwent a major resection after 31 March 2020.
NBOCA have published a new paper looking at variation in outcomes following systemic anti-cancer therapy (SACT) delivery.
NBOCA have published a new paper looking at colorectal cancer survival and dementia.
NBOCA has published a paper on outcomes in patients with colorectal cancer and inflammatory bowel disease.
The final date for uploading data for the NBOCA 2022 report will be 10th June.
Copyright © 2023 National Bowel Cancer Audit | Lovingly Crafted by Mixd